Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
SCAD (Stem Cell & Device Laboratory, Inc. ) logo — Regenerate damaged nerves! We are developing the world's fir...

SCAD (Stem Cell & Device Laboratory, Inc. )

Regenerate damaged nerves! We are developing the world's first cell therapy with stem cell derived Schwann cell.

Founded 2014 Japan Japan 4 employees Series B Total: $710.00M Health Care

General Information

Company Name SCAD (Stem Cell & Device Laboratory, Inc. )
Founded Year 2014
Location Japan Japan
Employees 4
Industries Health Care
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with SCAD (Stem Cell & Device Laboratory, Inc. ). To contact SCAD (Stem Cell & Device Laboratory, Inc. ), visit scad-kyoto.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SCAD (Stem Cell & Device Laboratory, Inc. ) compare?

A PDF of SCAD (Stem Cell & Device Laboratory, Inc. ) and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SCAD (Stem Cell & Device Laboratory, Inc. ) soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SCAD (Stem Cell & Device Laboratory, Inc. )

Stem Cell & Device Laboratory, Inc. (SCAD) is a Japan-based health care startup founded in 2014. The company's slogan "Developing iPS Drug Discovery" highlights its focus on developing an innovative evaluation system using disease model cells. SCAD recently secured a significant ¥510.00M Series B investment on 17 October 2017, with backing from a consortium of notable investors including Mitsubishi UFJ Capital, Nissay Capital, SMBC Venture Capital, Sosei CVC, Kyogin Lease & Capital, and Kyoto University Innovation Capital. This impressive investment underscores the potential of SCAD's disruptive approach in the field of drug discovery and positions the company for accelerated growth and further advancements in the health care industry.

Business keywords: iPS, drug discovery, cell application products, disease model cells, Stem Cell, device laboratory, pharmaceuticals, biomedical research, cell therapy, regenerative medicine

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B ¥510.00M 6
Mitsubishi UFJ Capital Nissay Capital SMBC Venture Capital
Mitsubishi UFJ Capital, Nissay Capital +4
17 Oct 2017
Series A ¥200.00M 3
SMBC Venture Capital KSP Kyoto University Innovation Capital Co., Ltd
SMBC Venture Capital, KSP +1
19 May 2016

SCAD (Stem Cell & Device Laboratory, Inc. ) Alternatives & Competitors

View All Alternatives
SCAD (Stem Cell & Device Laboratory, Inc. ) vs
StemoniX
StemoniX United States

Pre-plated, human iPSC-derived microOrgans for toxicology and drug discovery research

Convertible Note
1 employees
Biotechnology, Health Care
SCAD (Stem Cell & Device Laboratory, Inc. ) vs
Cellular Dynamics International
Cellular Dynamics International

Harness the Power of Fully Functional Human Cells for Innovative Drug Discovery and Therapeutics.

Debt Financing
Biotechnology, Health Care
SCAD (Stem Cell & Device Laboratory, Inc. ) vs
Cellusion Inc.
Cellusion Inc. Japan

Regenerating Human Potential. More Freedom and More Smiles to the World.

Series C
15 employees
Biotechnology, Health Care
View all alternatives

FAQ About SCAD (Stem Cell & Device Laboratory, Inc. )

Regenerate damaged nerves! We are developing the world's first cell therapy with stem cell derived Schwann cell.
SCAD (Stem Cell & Device Laboratory, Inc. ) was founded in 2014.
SCAD (Stem Cell & Device Laboratory, Inc. ) is headquartered in Japan.
SCAD (Stem Cell & Device Laboratory, Inc. ) operates in Health Care. Its work centres on iPS, drug discovery, cell application products and disease model cells.
SCAD (Stem Cell & Device Laboratory, Inc. ) has approximately 4 employees.
SCAD (Stem Cell & Device Laboratory, Inc. ) has completed 2 funding rounds, raising a total of $710.00M. The latest funding stage is Series B.
Top alternatives and competitors to SCAD (Stem Cell & Device Laboratory, Inc. ) include StemoniX, Cellular Dynamics International, Cellusion Inc., PrimeCell Bioscience, a.s., APstem Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SCAD (Stem Cell & Device Laboratory, Inc. ) and StemoniX are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SCAD (Stem Cell & Device Laboratory, Inc. ), https://bouncewatch.com/company/stem-cell-device-laboratory-inc-scad, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes